Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New pig antibiotics to have biosecurity focus
There was an 18 per cent rise in pig sector antibiotic useage in 2023.

The sector aims to break the cycle that drives antibiotic use. 

Following a rise in antibiotic usage in 2024, the next round of pig sector antibiotics are being developed with a biosecurity focus.

Proposals for the Target Task Force (TTF3) are being created by the Pig Health and Welfare Council’s Antimicrobial Usage Subgroup. 

The proposals will be advanced by Yorkshire producer and former NPA chair, Richard Lister, representing producers, and Dr Alex Thomsett, from the George Pig Practice, on behalf of the Pig Veterinary Society (PVS).

Similar to Ruma’s Target Task Force (TTF2) for antibiotic stewardship in farming, the new targets will contain numerical and non-numerical objectives. These objectives will be presented at the NPA spring regional meetings and the PVS spring meeting to gather feedback.

Richard Lister said: “All sectors have been encouraged to show ambition in their objectives, and this will be particularly reflected in our numerical target.”

The 2024 eMB pig sector antibiotic usage data is not expect to be finalised until late spring. However, it is expected to surpass the TTF3 target, and follows an 18 per cent rise in pig sector antibiotic usage to 85 mg/PCU in 2023. 

This rise has been linked to a range of health challenges, including swine dysentery, post-weaning diarrhoea or oedema disease, following the phasing out of zinc oxide.

“To address this, it is likely that one of the non-numerical targets will focus on biosecurity, so the sector can break the cycle of infection that drives antibiotic use,” said Alex.

“While some respiratory diseases, including porcine reproductive and respiratory syndrome [PRRS], can be acquired through aerosol transmission from neighbouring farms, many others, including swine dysentery, are more likely to enter a unit through a contaminated vehicle or other fomites.

“Addressing bio-exclusion on UK farms would prevent this cycle of disease spread and resultant antimicrobial use.”

Image (C) Shutterstock.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."